These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29796934)

  • 1. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
    Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
    Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
    Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
    Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy.
    Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N
    Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
    Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
    J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
    Hess DC; Sila CA; Furlan AJ; Wechsler LR; Switzer JA; Mays RW
    Int J Stroke; 2014 Apr; 9(3):381-6. PubMed ID: 23692637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.
    Kim SJ; Moon GJ; Chang WH; Kim YH; Bang OY;
    Trials; 2013 Oct; 14():317. PubMed ID: 24083670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients.
    Qiao LY; Huang FJ; Zhao M; Xie JH; Shi J; Wang J; Lin XZ; Zuo H; Wang YL; Geng TC
    Cell Transplant; 2014; 23 Suppl 1():S65-72. PubMed ID: 25333752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
    Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial.
    Jaillard A; Hommel M; Moisan A; Zeffiro TA; Favre-Wiki IM; Barbieux-Guillot M; Vadot W; Marcel S; Lamalle L; Grand S; Detante O;
    Transl Stroke Res; 2020 Oct; 11(5):910-923. PubMed ID: 32462427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial.
    de Celis-Ruiz E; Fuentes B; Alonso de Leciñana M; Gutiérrez-Fernández M; Borobia AM; Gutiérrez-Zúñiga R; Ruiz-Ares G; Otero-Ortega L; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E
    Cell Transplant; 2022; 31():9636897221083863. PubMed ID: 35301883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells.
    Oh SH; Choi C; Chang DJ; Shin DA; Lee N; Jeon I; Sung JH; Lee H; Hong KS; Ko JJ; Song J
    Cytotherapy; 2015 Aug; 17(8):1090-103. PubMed ID: 26031742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
    Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
    J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation.
    Zhang YC; Liu W; Fu BS; Wang GY; Li HB; Yi HM; Jiang N; Wang G; Zhang J; Yi SH; Li H; Zhang Q; Yang Y; Chen GH
    Cytotherapy; 2017 Feb; 19(2):194-199. PubMed ID: 27964826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
    Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
    Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.
    Honmou O; Houkin K; Matsunaga T; Niitsu Y; Ishiai S; Onodera R; Waxman SG; Kocsis JD
    Brain; 2011 Jun; 134(Pt 6):1790-807. PubMed ID: 21493695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.
    Lee JS; Hong JM; Moon GJ; Lee PH; Ahn YH; Bang OY;
    Stem Cells; 2010 Jun; 28(6):1099-106. PubMed ID: 20506226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
    Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
    BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.